KALARIS THERAPEUTICS, INC. Interest Receivable, Current
KALARIS THERAPEUTICS, INC. (KLRS) had Interest Receivable, Current of $0 as of 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Notes
us-gaap:InterestReceivableCurrent · last filed 2025-03-07
- 2024-12-31: Interest Receivable, Current $0.00.
- 2024-09-30: Interest Receivable, Current $53.00K.
- 2024-06-30: Interest Receivable, Current $96.00K.
- 2024-03-31: Interest Receivable, Current $181.00K.
| Period end | Interest Receivable, Current |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-07 |
| 2024-09-30 | $53.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $96.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $181.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $206.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | $234.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $106.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $244.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $157.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $261.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $91.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $172.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $50.00K 10-K · filed 2023-02-15 |
| 2021-09-30 | $151.00K 10-Q · filed 2021-11-05 |
| 2021-06-30 | $409.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $469.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $450.00K 10-K · filed 2022-02-10 |
| 2020-09-30 | $423.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $58.00K 10-Q · filed 2020-09-02 |
| 2019-12-31 | $262.00K 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |